KPC Pharmaceuticals,Inc. (SHA:600422)

China · Delayed Price · Currency is CNY

8.58

-0.12 (-1.38%)

May 20, 2026, 1:25 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Jan '21 Jan 1, 2021	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceutical Industry Segment	3.74B	4.87B	5.43B	4.90B	-
Pharmaceutical Industry Segment Growth	-23.29%	-10.34%	10.75%	-	-
Pharmaceutical Wholesale Division	3.27B	3.98B	3.37B	3.77B	-
Pharmaceutical Wholesale Division Growth	-17.95%	18.22%	-10.52%	-	-
Intersegment Elimination	-428.58M	-451.56M	-370.30M	-387.51M	-
Total	6.58B	8.40B	8.43B	8.28B	-
Total Growth	-21.74%	-0.34%	1.79%	-	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Jan '21 Jan 1, 2021	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	6.14B	-	-	-	8.10B
Foreign	133.03M	-	-	150.43M	147.61M
Foreign Growth	-	-	-	1.91%	-
Mainland China	-	-	-	8.12B	-
Hong Kong	-	-	-	8.15M	-
Total	6.27B	-	-	8.28B	8.25B
Total Growth	-	-	-	0.35%	-

Source: S&P Global Market Intelligence.